ESMO - The Christie Preceptorship on Lung Cancer 2025: Manchester

Slides and Webcasts from all ESMO Preceptorships are reserved to ESMO Members and registered participants, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.

The copyright protected educational resources from this event are for personal usage only and not to be shared with any third parties.

Learning objectives

• To learn about the evidence-base for lung cancer screening and novel diagnostic modalities
• To learn about the management of early-stage NSCLC and use of adjuvant treatments
• To understand the role of multi-modality treatment in locally advanced NSCLC and limited stage SCLC
• To learn about the management of patients with actionable driver mutations and novel targeted agents for advanced NSCLC
• To understand the role of immune-checkpoint blockade for lung cancer and to learn about novel immunotherapies
• To learn about treatment of NSCLC with oligometastatic disease
• To learn about the systemic treatment of mesothelioma and SCLC
• To learn about the role of supportive and palliative care for thoracic malignancies